Information management of medicine reimbursement to patients during the postinfarction period

Objective. To evaluate the clinical and economic effectiveness of the «Medicine Provision» information system during the postin-farction period. Material and methods. At the end of 2019, the «Medicine Provision» information system based on the scheme «attending physician of the vascular center — outpatient attending physician — pharmacy — outpatient clinic administration» was introduced in the re-gion. The effectiveness of the «Medicine Provision» information system in prescribing, dispensing, and monitoring reimbursed medicines was assessed based on clinical and economic data from the registers of accounts of the Territorial Fund for Compulsory Health Insurance. We compared two groups of patients with a history of myocardial infarction (MI) in 2018 and 2020. The long-term adverse outcomes and financial costs per unit of effectiveness for 2019 and 2021 were analyzed. The year 2018 group included 635 patients and the year 2020 included 571 patients. Long-term adverse outcomes of MI were considered as death from coronary heart disease (CHD), recurrent MI, emergency hospital admission, and ambulance calls for CHD. The financial costs in the postinfarction period consisted of the total cost of treatment at the emergency, outpatient, and emergency inpatient care. The unit of effectiveness was the absence of recurrent MI and a fatal outcome within one year after hospitalization for MI. Results. After the implementation of the «Medicine Provision» program, there was a 34% reduction in financial costs per unit of effectiveness in preventing recurrent MI and a 36% reduction in preventing deaths from CHD, a statistically significant decrease in the proportion of patients who had emergency hospitalizations from 13.9% to 9.6%, and a 7.1 to 4.2% reduction in the proportion of patients with fatal outcomes from CHD. Conclusion. Management of preferential medicine provision during the postinfarction period, based on digital data, computer soft-ware, and information integration of medical and pharmacy organizations, shows a significant reduction in the proportion of emergency hospitalizations and fatal outcomes from coronary heart disease, accompanied by a decrease in financial costs for the prevention of death from coronary heart disease and repeated myocardial infarction. © 2022, Media Sphera Publishing Group. All rights reserved.